Frontiers in Oncology | Cancer Molecular Targets and Therapeutics

Review

Published on 11 Feb 2025

New options for targeting TRPV1 receptors for cancer treatment: odorous Chinese herbal medicine

in Cancer Molecular Targets and Therapeutics

Minghui Zhang
Zongao Wang
Shaojun Liu
Yuxuan Li
Yanting Gong
Min Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1488289

1,125 views

Review

Published on 11 Feb 2025

Androgen receptor dynamics in prostate cancer: from disease progression to treatment resistance

in Cancer Molecular Targets and Therapeutics

Caihong Li
Dongkai Cheng
Peng Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1542811

3,213 views
4 citations

Editorial

Published on 11 Feb 2025

Editorial: Drug repurposing for cancer treatment: current and future directions

in Cancer Molecular Targets and Therapeutics

Marios Lampros
Nikolaos Vlachos
Georgios D. Lianos
Christina Bali
George A. Alexiou

Frontiers in Oncology

doi 10.3389/fonc.2025.1550672

913 views

Case Report

Published on 10 Feb 2025

A rare case of vision loss caused by leptomeningeal metastasis of lung adenocarcinoma: a case report and literature review

in Cancer Molecular Targets and Therapeutics

Zhihua Li
Jian Chu
Wennan Shen
Junnan Chen
Yuemei Dong
Manze Zhang
Nan Zhao
Wei Zhao
Haoran Zha
Ning Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1484383

948 views

Mini Review

Published on 10 Feb 2025

Improving CD3 bispecific antibody therapy in solid tumors using combination strategies

in Cancer Molecular Targets and Therapeutics

Katy Lloyd
Jim Middelburg
Vitalijs Ovcinnikovs
Nora Pencheva
Kristel Kemper
Thorbald van Hall

Frontiers in Oncology

doi 10.3389/fonc.2025.1548446

2,790 views

Review

Published on 07 Feb 2025

Biological functions of 5-methylcytosine RNA-binding proteins and their potential mechanisms in human cancers

in Cancer Molecular Targets and Therapeutics

Tingting Zhao
Zhe Zhang
Zhuo Chen
Guozheng Xu
Yongxi Wang
Fang Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1534948

2,048 views

Review

Published on 07 Feb 2025

Organoid models: applications and research advances in colorectal cancer

in Cancer Molecular Targets and Therapeutics

Yijie Wu
Yu Sha
Xingpo Guo
Ling Gao
Jian Huang
Song-Bai Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1432506

1,795 views
1 citation

Mini Review

Published on 06 Feb 2025

DNA methylation and immune evasion in triple-negative breast cancer: challenges and therapeutic opportunities

in Cancer Molecular Targets and Therapeutics

Wen-yu Cai
Xin-xian Cai
Yi-ran Fei
Rui Ye
Ding-ming Song
Dan Hu
Wan-wan Zhang
Ming-fei Xia
Xiao-xiao Yang

Frontiers in Oncology

doi 10.3389/fonc.2025.1534055

2,108 views
1 citation

Original Research

Published on 06 Feb 2025

Evaluation of patient immunocompetence for immune checkpoint inhibitor therapy using the psoas muscle index: a retrospective cohort study

in Cancer Molecular Targets and Therapeutics

Toshiaki Tsurui
Kazuyuki Hamada
Emiko Mura
Risako Suzuki
Nana Iriguchi
Tomoyuki Ishiguro
Yuya Hirasawa
Ryotaro Ohkuma
Masahiro Shimokawa
Hirotsugu Ariizumi

Frontiers in Oncology

doi 10.3389/fonc.2025.1499650

1,071 views

Original Research

Published on 06 Feb 2025

A pan-cancer analysis of homeobox family: expression characteristics and latent significance in prognosis and immune microenvironment

in Cancer Molecular Targets and Therapeutics

Yuanhui Wang
Jie Gao
Ziyi Ren
Ziyi Shen
Wei Gu
Qinyi Miao
Xiaomeng Hu
Yan Wu
Wei Liu
Jia Jia

Frontiers in Oncology

doi 10.3389/fonc.2025.1521652

1,273 views

Systematic Review

Published on 04 Feb 2025

Exploring the role of artificial intelligence in chemotherapy development, cancer diagnosis, and treatment: present achievements and future outlook

in Cancer Molecular Targets and Therapeutics

Bassam Abdul Rasool Hassan
Ali Haider Mohammed
Souheil Hallit
Diana Malaeb
Hassan Hosseini

Frontiers in Oncology

doi 10.3389/fonc.2025.1475893

3,635 views
2 citations

Review

Published on 03 Feb 2025

MicroRNA155 in non-small cell lung cancer: a potential therapeutic target

in Cancer Molecular Targets and Therapeutics

Xiangju Wei
Xianmin Xiong
Ze Chen
Bi Chen
Cantang Zhang
Wenhui Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1517995

1,323 views

Correction

Published on 31 Jan 2025

Corrigendum: First-in-human phase 1 dose-escalation results with livmoniplimab, an antibody targeting the GARP: TGF-ß1 complex, as monotherapy and in combination with the anti–PD-1 antibody budigalimab in patients with advanced solid tumors

in Cancer Molecular Targets and Therapeutics

Toshio Shimizu
John Powderly
Albiruni Abdul Razak
Patricia LoRusso
Kathy D. Miller
Steven Kao
Sarah Kongpachith
Catherine Tribouley
Michelle Graham
Brian Stoll

Frontiers in Oncology

doi 10.3389/fonc.2024.1544394

888 views

Review

Published on 30 Jan 2025

Advances in non-apoptotic regulated cell death: implications for malignant tumor treatment

in Cancer Molecular Targets and Therapeutics

Yizheng Zhang
Shiqi Yi
Mingyuan Luan

Frontiers in Oncology

doi 10.3389/fonc.2025.1519119

2,135 views

Technology and Code

Published on 29 Jan 2025

VIBE: an R-package for VIsualization of Bulk RNA Expression data for therapeutic targeting and disease stratification

in Cancer Molecular Targets and Therapeutics

Indu Khatri
Saskia D. van Asten
Leandro F. Moreno
Brandon W. Higgs
Christiaan Klijn
Francis Blokzijl
Iris C. R. M. Kolder

Frontiers in Oncology

doi 10.3389/fonc.2024.1441133

1,367 views

Original Research

Published on 29 Jan 2025

Dihydrotanshinone I enhanced BRAF mutant melanoma treatment efficacy by inhibiting the STAT3/SOX2 signaling pathway

in Cancer Molecular Targets and Therapeutics

Xing Luo
Yi Duan
Jinwei He
CongGai Huang
Jun Liu
Yifan Liu
Mengdei Xu
Qiong Dai
Zhihui Yang

Frontiers in Oncology

doi 10.3389/fonc.2025.1429018

954 views
1 citation